Short-Term Immune-Checkpoint Inhibition Partially Rescues Perturbed Bone Marrow Hematopoiesis in Mismatch-Repair Deficient Tumors

0
163
Using anti-PD1 and anti-LAG-3 Immune-checkpoint inhibitor treatments, researchers investigated the effect of bone marrow hematopoiesis in tumor-bearing Msh2loxP/loxP;TgTg(Vil1-cre) mice.
[Oncoimmunology]
Full ArticleGraphical Abstract